| 10478501 |
Method of treating disorders using a pharmaceutical composition of oligopeptides |
Christiane Amendt, Marcus Eber |
2019-11-19 |
$484,220,000 |
| 8993261 |
Antibodies for the detection of integrin complexes in FFPE material |
Claudia Wilm, Francesc Mitjans |
2015-03-31 |
$66,424,000 |
| 8562986 |
Engineered anti-alpha V-integrin hybrid antibodies |
Diane Hahn, Francesc Mitjans, Jaume Adan, Kin-Ming Lo |
2013-10-22 |
$71,032,000 |
| 8420348 |
Antibodies for the detection of integrin complexes in FFPE material |
Claudia Wilm, Francesc Mitjans |
2013-04-16 |
$60,818,000 |
| 8067197 |
Soluble recombinant αvβ3 adhesion receptor |
Beate Diefenbach, Detelv Güssow, Raj J. Mehta, Eilish Cullen, Alex Brown |
2011-11-29 |
$49,501,000 |
| 7632951 |
Inhibitors of integrin ανβ6 |
Oliver Schadt, Alfred Jonczyk, Wolfgang Staehle |
2009-12-15 |
$106,751,000 |
| 7138417 |
Inhibitors of integrin αvβ6 |
Wolfgang Staehle, Oliver Schadt, Alfred Jonczyk |
2006-11-21 |
$113,439,000 |
| 7135587 |
Urea and urethane derivatives as integrin inhibitors |
Wolfgang Staehle, Alfred Jonczyk, Oliver Schadt |
2006-11-14 |
$119,176,000 |
| 7125699 |
Identification of a human N-terminal acetyltransferase gene |
Klaus Duecker |
2006-10-24 |
$43,547,000 |
| 7060707 |
Isoquinoline derivatives |
Matthias Wiesner, Horst Kessler, Georgette Thumshirn, Dirk Weber, Dirk Gottschling |
2006-06-13 |
$31,052,000 |
| 7037699 |
Human extracellular signal regulated kinases |
Burkhard Scharm, Marcus Frohme, Joerg Hoheisel |
2006-05-02 |
$360,957,000 |
| 7029652 |
Method of treating tumors |
Siegfried Matzku, Patricia Burke, Gerald L. DeNardo, Sally J. DeNardo |
2006-04-18 |
$34,279,000 |
| 6849646 |
Chromenone and chromanone derivatives as integrin inhibitors |
Claus Fittschen, Joachim Marz, Peter Raddatz, Matthias Wiesner |
2005-02-01 |
$107,925,000 |
| 6743810 |
Indol-3-yl derivatives |
Matthias Wiesner, Rudolf Gottschlich |
2004-06-01 |
$135,889,000 |
| 6683051 |
Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
Alfred Jonczyk, Astrid Perschl, Sigrid Rösener, Jutta Haunschild |
2004-01-27 |
$143,642,000 |
| 6649613 |
Diacylhydrazine derivatives |
Gunter Holzemann, Horst Kessler, Christoph Gibson, Gabor Sulyok |
2003-11-18 |
$41,432,000 |
| 6645991 |
&agr;v&bgr;3 integrin inhibitors |
Alfred Jonczyk, Oliver Schadt |
2003-11-11 |
$41,694,000 |
| 6566491 |
Cyclopeptide derivatives |
Alfred Jonczyk, Beate Diefenbach, Arne Sutter, Horst Kessler |
2003-05-20 |
$78,142,000 |
| 6559144 |
Bicyclic amino acids |
Beate Diefenbach, Joachim Marz, Peter Raddatz, Friedrich Rippmann, Matthias Wiesner |
2003-05-06 |
$98,996,000 |
| 6534478 |
Cyclic azapeptides with angiogenic effect |
Alfred Jonczyk, Horst Kessler, Jochen Wermuth, Jörg Schmitt |
2003-03-18 |
$63,255,000 |
| 6521646 |
Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis |
Wolfgang Stahle, Rudolf Gottschlich |
2003-02-18 |
$96,600,000 |
| 6333308 |
Cyclic peptide derivatives |
Gunter Holzemann, Claus Fittschen |
2001-12-25 |
|
| 6326403 |
Diacylhydrazine derivatives as integrin inhibitors |
Gunter Holzemann, Horst Kessler, Christoph Gibson, Jörg Schmitt |
2001-12-04 |
$293,132,000 |
| 6127335 |
Cyclic adhesion inhibitors |
Alfred Jonczyk, Beate Diefenbach, Horst Kessler, Marcus Koppitz |
2000-10-03 |
$156,149,000 |
| 6001961 |
Cyclic adhesion inhibitors |
Alfred Jonczyk, Beate Diefenbach, Arne Sutter, Gunter Holzemann, Horst Kessler +1 more |
1999-12-14 |
$144,131,000 |
